Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

31.10.18	ViiV Healthcare Announces Positive Phase 3 Results From BRIGHTE Study (RTTNews)
30.10.18	Pfizer Narrows 2018 Revenues Guidance (RTTNews)
30.10.18	Pfizer Inc. Q3 adjusted earnings Beat Estimates (RTTNews)
30.10.18	PFIZER REPORTS THIRD-QUARTER 2018 RESULTS (Businesswire)
29.10.18	ViiV Healthcare Presents Three-year Data For Injectable, Two-drug HIV Regimen (RTTNews)
29.10.18	Biotech Stocks Facing FDA Decision In November (RTTNews)
29.10.18	Pfizer In Clinical Development Deal With Novartis To Advance Treatment Of NASH (RTTNews)
29.10.18	Pfizer Announces Clinical Development Agreement with Novartis to Advance the Treatment of NASH (Businesswire)
24.10.18	CMTA Fast Tracks NDA Filing, USNA In Good Health, DERM To Report Data In Apr. (RTTNews)
24.10.18	Complete Results from First Study in Ongoing Phase 3 Program for Tanezumab Demonstrated Significant Improvement in Pain and Function in Osteoarthritis Patients (Businesswire)
23.10.18	Bain Capital And Pfizer Create New CNS Company Cerevel Therapeutics (RTTNews)
20.10.18	Pfizer Presents Overall Survival Data From PALOMA-3 Trial of IBRANCE® (palbociclib) in Patients With HR+, HER2- Metastatic Breast Cancer (Businesswire)
18.10.18	Merck Says Pivotal Phase 3 KEYNOTE-426 Trial Meets Both Primary Endpoints (RTTNews)
12.10.18	Pfizer To Pay $700,000 To Settle 'deceptive Advertising' Charges (RTTNews)
09.10.18	Pfizer Announces New Executive Team - Quick Facts (RTTNews)
09.10.18	Pfizer Announces Executive Leadership Team (Businesswire)
09.10.18	Myriad Signs Commercialization Plan With Pfizer - Quick Facts (RTTNews)
01.10.18	Pfizer: Albert Bourla To Succeed Ian Read As CEO Effective Jan. 1 (RTTNews)
01.10.18	Pfizer Announces CEO Succession (Businesswire)
28.09.18	QIAGEN Receives FDA Approval To Expand Use Of EGFR Test In Lung Cancer (RTTNews)
28.09.18	FDA Approves Pfizer's Lung Cancer Drug (RTTNews)
27.09.18	Pfizer Declares 34-Cent Fourth-Quarter 2018 Dividend (Businesswire)
24.09.18	Astellas Pharma Gets Positive CHMP Opinion For Xtandi - Quick Facts (RTTNews)
20.09.18	Pfizer: PF-06482077 Receives Breakthrough Therapy Designation - Quick Facts (RTTNews)
20.09.18	Pfizer Granted FDA Breakthrough Therapy Designation for 20-Valent Pneumococcal Conjugate Vaccine for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older (Businesswire)
18.09.18	Pfizer Invites Public to View and Listen to Webcast of October 30 Conference Call with Analysts (Businesswire)
18.09.18	Pfizer Reports Addl Analyses From Tafamidis Phase 3 ATTR-ACT Study (RTTNews)
18.09.18	New Sub-group Analyses from the Tafamidis Phase 3 Transthyretin Amyloid Cardiomyopathy (ATTR-ACT) Study Presented at 2018 HFSA Annual Scientific Meeting (Businesswire)
18.09.18	Pharma Companies Avoid $3.8 Bln In Tax Per Year, Says Oxfam (RTTNews)
17.09.18	Atomwise Enters Evaluation Agreement With Pfizer - Quick Facts (RTTNews)
15.09.18	Pfizer Reports Positive Phase 2 Data Of JAK Inhibitors In Alopecia Areata (RTTNews)
15.09.18	Pfizer Presents Positive Phase 2 Data in Alopecia Areata During Late-Breaker Session at the 27th European Academy of Dermatology and Venereology (EADV) Congress (Businesswire)
14.09.18	ViiV Files Application To EMA For Two-drug Regimen To Treat HIV - Quick Facts (RTTNews)
11.09.18	Merck, Pfizer Report Positive Top-line Results From Phase III JAVELIN 101 Study (RTTNews)
06.09.18	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
05.09.18	Pfizer Gets Breakthrough Therapy Designation From FDA For PF-06651600 (RTTNews)
05.09.18	Pfizer Receives Breakthrough Therapy Designation from FDA for PF-06651600, an oral JAK3 Inhibitor, for the Treatment of Patients with Alopecia Areata (Businesswire)
05.09.18	Pfizer Prices $5bln Debt Offering (RTTNews)
05.09.18	Pfizer Prices $5,000,000,000 Debt Offering (Businesswire)
31.08.18	Biotech Stocks Facing FDA Decision In September (RTTNews)
30.08.18	Pfizer Terminates Two Duchenne Muscular Dystrophy Studies (RTTNews)
30.08.18	Pfizer Terminates Domagrozumab (PF-06252616) Clinical Studies for the Treatment of Duchenne Muscular Dystrophy (Businesswire)
29.08.18	Pfizer Recalls Children's Advil Recall Due To Overdose Concerns (RTTNews)
27.08.18	Tafamidis Phase 3 Transthyretin Amyloid Cardiomyopathy (ATTR-ACT) Study Results Presented as Late-Breaking Data at the ESC Congress 2018 (Businesswire)
23.08.18	EXAS Soars On Pfizer Deal, MYND Delighted, ADMP Faces FDA In Sep. (RTTNews)
22.08.18	Pfizer and Astellas Amend Clinical Research Protocols for Two Phase 3 Trials of Enzalutamide in Patients with Hormone-Sensitive Prostate Cancer (Businesswire)
22.08.18	Exact Sciences & Pfizer To Co-promote Cologuard (RTTNews)
20.08.18	Pfizer Invites Public to View and Listen to Webcast of August 27 Conference Call with Analysts and Investors to Review Tafamidis Data Presentation at ESC Congress 2018 (Businesswire)
17.08.18	New Drugs Approved In July (RTTNews)
16.08.18	BioNTech, Pfizer To Develop MRNA-based Vaccines For Prevention Of Influenza (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

22:33		Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone
20:03		Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester
18:01		Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus
17:58		Freundlicher Handel: Börsianer lassen SPI schlussendlich steigen
17:58		Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen
17:58		Handel in Frankfurt: TecDAX letztendlich in Grün

22:33

Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone

20:03

Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester

18:01

Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus

17:58

Freundlicher Handel: Börsianer lassen SPI schlussendlich steigen

17:58

Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen

17:58

Handel in Frankfurt: TecDAX letztendlich in Grün